There is no better feeling than to receive the admiration of your child … To know that what you do can not only improve the world for others but also means the world to your reason for everything – your family. This was the experience for Waters’ Davy Petit, who recently received a text from his son expressing pride in his father’s work in the fight against COVID-19.
Waters’ latest product launch will supercharge the role of mass spectrometry research in the fight against SARS-CoV-2. Scientists can now directly quantify specific viral NCAP peptides in a highly reproducible manner with the Waters SARS-CoV-2 LC-MS Kit (RUO), allowing breakthrough research of the SARS-CoV-2 virus.
An interview with Ming Gao, Ph.D., Upward BioInformatics Ideation Post-Doctoral Fellow at Waters Corporation Ming Gao joined Waters Corporation in January 2021 as an Upward BioInformatics Ideation Post-Doctoral Fellow. Ming earned a B.S. in Chemistry… Read more >
Critical SARS-CoV-2 PCR based diagnostics have not been immune to the supply chain disruptions so common during the COVID-19 pandemic. While the biggest disruption for PCR based testing was RNA extraction kits, enzymes and PCR primers have been affected as well. At Waters, we’ve kept a close eye on the role that high-quality preparative HPLC columns play in the PCR primer and probe supply chain. As we forge ahead through this pandemic and beyond, we will continue to help ensure adequate quality and supply of PCR primers and probes for diagnostics and routine use.
The worldwide coronavirus pandemic has changed the way that scientists and companies work. Learn how the Waters COVID-19 Innovation Response Team enabled the critical collaboration and pooling of expertise that enabled fast and safe vaccine development.
Waters Innovation Response Team gathered quickly in March 2020 to support the scientific response to the COVID-19 pandemic, connecting the expertise contained within Waters to the global fight against SARS-CoV-2. Learn more about the impact of the Waters Innovation Response Team over the past year.
During 2020, we collaborated with many of our customers to develop targeted liquid chromatography–mass spectrometry/mass spectrometry (LC-MS/MS) methods to detect SARS-CoV-2 (the virus that causes COVID-19) from biological samples. However, the combination of the biological… Read more >
At Waters, our purpose has always been centered on enhancing human health and well-being. Today, that purpose is more important than ever. From the onset of the pandemic, Waters has partnered with organizations around the world to bring our resources… Read more >
At Waters, we have a long history of working alongside the scientific community in times of need through collaboration. Today, as the world continues to battle COVID-19, that collaborative approach is more important than ever. Ultimately, this challenge is… Read more >
Early on in the pandemic, Adam Beard, Waters’ Vice President of Global Services, wrote about how our employees were “Delivering Benefit While Supporting the Front Lines of a Global Pandemic” in a post on LinkedIn. Today,… Read more >
